check_circleStudy Completed
Hypertension
Bayer Identifier:
12729
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
The Real-Life Efficacy and Safety of Telmisartan in Patients with Arterial Hypertension
Trial purpose
The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.
Key Participants Requirements
Sex
BothAge
18 YearsTrial summary
Enrollment Goal
5448Trial Dates
September 2006 - January 2008Phase
N/ACould I Receive a placebo
NoProducts
Kinzal/Pritor (Telmisartan, BAY68-9291)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many locations, Croatia | |
Completed | Many locations, Slovenia | |
Completed | Many locations, Poland | |
Completed | Many locations, Slovakia |
Primary Outcome
- Efficacy and safety of the treatment with telmisartan reported by the physiciandate_rangeTime Frame:At the both of planned control visits. (Approx. interval between visits 3 months)enhanced_encryptionYesSafety Issue:
Secondary Outcome
- Changes in metabolic parameters in telmisartan treated patientsdate_rangeTime Frame:At the both of planned control visits. (Approx. interval between visits 3 months)enhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A